Back

Quantum BioPharma applies to delist Class B shares from CSE

Verifying
  • Quantum BioPharma applied to voluntarily delist Class B shares from the CSE.
  • September 4, 2026, is expected to be the final CSE trading day, pending approval.
  • Class B shares will continue trading on Nasdaq, the Frankfurt Stock Exchange and Upstream.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.